Executive Vice President, Chief Financial Officer, and Chief Business Officer, Sarepta Therapeutics, Inc.
Mr. Mahatme is executive vice president and chief financial officer of Sarepta Therapeutics where he leads Sarepta’s finance, business development, technical operations, facilities, IT and investor and public relations functions. From January 2006 to November 2012, Mr. Mahatme worked at Celgene Corporation, a biopharmaceutical company, where he served in various roles, including senior vice president of corporate development, senior vice president of finance, corporate treasurer, and head of tax. While at Celgene, Mr. Mahatme built the treasury and tax functions before establishing the corporate development department, focused on strategic, targeted initiatives including commercial development in emerging markets, acquisitions and licensing, and global manufacturing expansion. Prior to working at Celgene, Mr. Mahatme worked for Pfizer Inc. for eight and a half years in senior roles in business development and corporate tax. Mr. Mahatme started his career at Ernst & Young LLP, where he advised multinational corporations on a broad range of transactions. Mr. Mahatme holds Master of Laws (LL.M.) degrees from Cornell Law School and New York University School of Law and is a member of the New York State Bar Association. In addition to Aeglea, Mr. Mahatme is also a board member of Flexion Therapeutics, Inc. and Elcelyx Therapeutics, Inc., both biopharmaceutical companies.